CD79A and COVID-19: This is in line with reports of other groups describing the induction of spike-specific IgG and IgA antibodies by mRNA vaccines in HIV-1-uninfected subjects, with anti-spike antibody levels being consistently higher in vaccinated persons compared to COVID-19 convalescent and serum IgG levels being higher than IgA levels [31,32,33,34,35].